American Regent Executive and Leadership Team

Paul Diolosa, the President & Chief Executive Officer at American Regent, directs the overall strategic vision and operational execution for the Daiichi Sankyo Group Company. Diolosa architects the company's market positioning and growth initiatives, ensuring alignment with the broader organizational objectives of supplying high-quality sterile injectables. Overseeing all business units, the President & Chief Executive Officer drives innovation in product development and manufacturing processes across American Regent's New York, Ohio, and Pennsylvania locations. This leadership role involves fostering key relationships with healthcare providers, clinics, and hospitals nationwide, solidifying the company's reputation for reliability and quality. By championing operational excellence, Paul Diolosa ensures the company effectively serves its customer base across the United States and Canada, directly contributing to enhanced patient care through a consistent supply of critical medications.

Joseph Boyle, the Vice President, Finance & Chief Financial Officer at American Regent, manages all financial operations and fiscal strategy for the organization. Boyle oversees budgeting, forecasting, and financial reporting, ensuring robust fiscal health and compliance with regulatory standards. This executive role involves strategic financial planning to support the development, manufacturing, and supply of sterile injectables across the United States and Canada. The Chief Financial Officer directs capital allocation, investment strategies, and risk management to optimize profitability and sustain growth for the Daiichi Sankyo Group Company. By maintaining stringent financial controls, Joseph Boyle ensures the efficient allocation of resources to support operations in New York, Ohio, and Pennsylvania, thereby enabling the consistent delivery of high-quality pharmaceutical products to healthcare providers nationwide.

Ravi Tayi, the Chief Medical Officer at American Regent, provides critical medical and scientific leadership, guiding the company's product development and quality assurance initiatives. Tayi ensures that all manufactured sterile injectables meet the highest standards of safety, efficacy, and regulatory compliance, directly supporting healthcare providers, clinics, and hospitals. This role involves close collaboration with research and development teams to advance the company's pipeline of pharmaceutical products. The Chief Medical Officer also plays a key part in evaluating new therapeutic areas and potential product acquisitions, aligning medical strategy with business objectives. By offering expert medical insights, Ravi Tayi contributes significantly to American Regent's mission of supplying essential medications and upholding its reputation for quality across the United States and Canada.

Joseph Oestreicher, the Chief People Officer at American Regent, leads all human capital strategies and organizational development initiatives. Oestreicher cultivates a high-performance culture that supports the company's mission of developing and supplying high-quality sterile injectables. This executive function involves overseeing talent acquisition, employee engagement, and professional development programs across American Regent's operational sites in New York, Ohio, and Pennsylvania. The Chief People Officer ensures that the workforce possesses the necessary expertise and dedication to meet the demands of the pharmaceutical manufacturing sector. By fostering a supportive and dynamic work environment, Joseph Oestreicher drives employee retention and optimizes team performance, directly contributing to the company's ability to serve healthcare providers effectively throughout the United States and Canada.

Gretchen Fritz, the Vice President, Chief Legal Officer at American Regent, directs all legal affairs and ensures corporate compliance across the organization. Fritz provides strategic counsel on regulatory matters, intellectual property, and contract negotiations, safeguarding the company's interests. This leadership position involves overseeing the legal framework that supports the development, manufacturing, and distribution of sterile injectables to healthcare providers nationwide. The Chief Legal Officer manages risk mitigation strategies and ensures adherence to all applicable laws and industry standards within the United States and Canada. By providing expert legal guidance, Gretchen Fritz supports American Regent's commitment to quality and operational integrity, enabling the company to navigate complex legal landscapes effectively and maintain its trusted position in the pharmaceutical supply chain.